INO-3107 / Inovio  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
INO-3107 / Inovio
NCT04398433: INO-3107 With Electroporation (EP) in Participants With HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP)

Completed
1/2
32
US
INO-3107, CELLECTRA™ 2000
Inovio Pharmaceuticals
Respiratory Papillomatosis
12/22
12/22

Download Options